Dr. Chinazo Cunningham is the principal investigator in a potentially groundbreaking study into whether marijuana use could reduce the need for addictive opioids in pain management. It’s a rare opportunity given the federal restrictions on studying marijuana. Since 1970, it’s been listed as a Schedule I drug, meaning it has no medical use and there is a high potential for abuse. Despite 30 states legalizing medical marijuana, the federal government maintains there’s not enough research to suggest it has medical benefits, and this position keeps pot from being studied by researchers. Dr. Cunningham joins Soledad O’Brien to talk about her study and the Catch-22 of studying marijuana in the U.S.
Searching for “Forgotten America”
November 26, 2016Searching for “Forgotten America”
November 26, 2016
Who Will Be First in Line for a COVID-19 Vaccine?
August 9, 2020Who Will Be First in Line for a COVID-19 Vaccine?
August 9, 2020
Another Health Crisis on the Horizon: Managing Stress, Anxiety During COVID-19
August 2, 2020Another Health Crisis on the Horizon: Managing Stress, Anxiety During COVID-19
August 2, 2020
Rural Hospitals On Life Support During the Pandemic
August 2, 2020Rural Hospitals On Life Support During the Pandemic
August 2, 2020
How Doctors Are Treating Patients with COVID-19
July 26, 2020How Doctors Are Treating Patients with COVID-19
July 26, 2020
Getting Ahead of COVID-19: How Contact Tracers Can Help Curb the Spread
July 26, 2020Getting Ahead of COVID-19: How Contact Tracers Can Help Curb the Spread
July 26, 2020
Outbreak: The First Response
June 28, 2020Outbreak: The First Response
June 28, 2020
Finding Shelter During the Pandemic: How Seattle Tackled its Homeless Crisis
June 14, 2020Finding Shelter During the Pandemic: How Seattle Tackled its Homeless Crisis
June 14, 2020
